Stocks News

LAST PRICE
52.7000
TODAY'S CHANGE (%)
Trending Down-0.8400 (-1.5689%)

Bid / Lots
52.6900/ 1
Ask / Lots
52.7100/ 1
Open / Previous Close
53.5300 / 53.5400
Day Range
Low 52.0800
High 54.3200
52 Week Range
Low 52.0800
High 170.4700
Volume
3,709,669
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- Market Chatter: Bancel Steps Down as Moderna Sales Chief, Keeps CEO Post, from 1 hour ago by MT Newswires
  1 hour ago by MT Newswires
  Companies Mentioned: MRNA
  01:00 PM EST, 11/05/2024 (MT Newswires) -- Moderna (MRNA) Chief Executive Stephane Bancel is stepping down as chief commercial officer but will remain CEO of the company, Bloomberg reported Tuesday, citing a person familiar with the matter. Moderna ...
- --Moderna's Bancel Steps Down as Sales Chief, Keeps CEO Post, Bloomberg Reports, from 1 hour ago by MT Newswires
  1 hour ago by MT Newswires
  Companies Mentioned: MRNA
  12:58 PM EST, 11/05/2024 (MT Newswires) -- Price: 52.37, Change: -1.17, Percent Change: -2.19 ...
- Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024, from 5 hours ago by PR Newswire
  5 hours ago by PR Newswire
  Companies Mentioned: MRNA, CARM
  Pre-clinical data demonstrate robust anti-tumor activity and a novel off-the-shelf approach for GPC3+ solid tumors
  Carisma Therapeutics Inc.(Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced the upcoming presentation of new pre-clinical data on its anti-GPC3in vivochimeric antigen receptor macrophage and monocyte (together, "CAR-M")therapy for the treatment of hepatocellular carcinoma ("HCC"), developed in collaboration with Moderna, Inc. (Nasdaq: MRNA). The data will be presented in a poster session at the Society for Immunotherapy of Cancer ("SITC") Annual Meeting in Houston, Texas, on November 8, 2024.
- Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: MRNA, CARM
  
  Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024
  
  PR Newswire
  
  PHILADELPHIA, Nov. 5, 2024
Yesterday
- DJ Moderna Is Maintained at Underweight by JP Morgan, from 9:59AM ET on Monday Nov 04, 2024 by Dow Jones
  9:59AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: MRNA
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/MRNA/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 04, 2024 09:59 ET (14:59 GMT)

Today
- DJ BioNTech Is Maintained at Hold by TD Cowen, from 11 minutes ago by Dow Jones
  11 minutes ago by Dow Jones
  Companies Mentioned: BNTX
- Market Chatter: Brookfield Asset Management Seeks Details of Grifols Related-Party Deals, from 39 minutes ago by MT Newswires
  39 minutes ago by MT Newswires
  Companies Mentioned: GRFS, BAM
Yesterday
- Sector Update: Health Care Stocks Retreat Late Afternoon, from 22 hours ago by MT Newswires
  22 hours ago by MT Newswires
  Companies Mentioned: NUWE, BNTX, KALV, PACS
- Sector Update: Health Care Stocks Softer in Afternoon Trading, from 1:59PM ET on Monday Nov 04, 2024 by MT Newswires
  1:59PM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: BNTX, AZN, PACS
- Sector Update: Health Care, from 1:35PM ET on Monday Nov 04, 2024 by MT Newswires
  1:35PM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: BNTX
- BioNTech Sees Full-Year Revenue at Low End of Guidance; Third-Quarter Results Rise, from 1:07PM ET on Monday Nov 04, 2024 by MT Newswires
  1:07PM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: PFE, BNTX
- European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading, from 11:20AM ET on Monday Nov 04, 2024 by MT Newswires
  11:20AM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: BBVA, NVO, PHG, TRIB, NCNA, AMRN, AKTX, MREO, BCYC, BNTX, CRTO, MTLS, DBVT, ADAP, BDRX, EDAP
- DJ BioNTech Is Maintained at Neutral by JP Morgan, from 9:50AM ET on Monday Nov 04, 2024 by Dow Jones
  9:50AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: BNTX
- DJ Biogen Is Maintained at Neutral by JP Morgan, from 9:47AM ET on Monday Nov 04, 2024 by Dow Jones
  9:47AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: BIIB
- Sector Update: Health Care Stocks Mixed Premarket Monday, from 9:08AM ET on Monday Nov 04, 2024 by MT Newswires
  9:08AM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: IBB, TGTX, XLV, ZTS, BNTX

Moderna Inc
NASDAQ:MRNAUnited States

Search Criteria

Today

Market Chatter: Bancel Steps Down as Moderna Sales Chief, Keeps CEO Post, from 1 hour ago by MT Newswires

--Moderna's Bancel Steps Down as Sales Chief, Keeps CEO Post, Bloomberg Reports, from 1 hour ago by MT Newswires

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024, from 5 hours ago by PR Newswire

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024, from 5 hours ago by Dow Jones

Yesterday

DJ Moderna Is Maintained at Underweight by JP Morgan, from 9:59AM ET on Monday Nov 04, 2024 by Dow Jones

Peers Headlines

Today

DJ BioNTech Is Maintained at Hold by TD Cowen, from 11 minutes ago by Dow Jones

Market Chatter: Brookfield Asset Management Seeks Details of Grifols Related-Party Deals, from 39 minutes ago by MT Newswires

Yesterday

Sector Update: Health Care Stocks Retreat Late Afternoon, from 22 hours ago by MT Newswires

Sector Update: Health Care Stocks Softer in Afternoon Trading, from 1:59PM ET on Monday Nov 04, 2024 by MT Newswires

Sector Update: Health Care, from 1:35PM ET on Monday Nov 04, 2024 by MT Newswires

BioNTech Sees Full-Year Revenue at Low End of Guidance; Third-Quarter Results Rise, from 1:07PM ET on Monday Nov 04, 2024 by MT Newswires

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading, from 11:20AM ET on Monday Nov 04, 2024 by MT Newswires

DJ BioNTech Is Maintained at Neutral by JP Morgan, from 9:50AM ET on Monday Nov 04, 2024 by Dow Jones

DJ Biogen Is Maintained at Neutral by JP Morgan, from 9:47AM ET on Monday Nov 04, 2024 by Dow Jones

Sector Update: Health Care Stocks Mixed Premarket Monday, from 9:08AM ET on Monday Nov 04, 2024 by MT Newswires